Healthcare Market Reports

Over the past few years, incidences of cardiovascular diseases have been witnessing a surge, coupled with rising number of cardiology intervention procedures around the world. Governments are making provisions of reimbursement support for patients with vascular diseases. The healthcare expenditure has also been experiencing a hike since recent past. Factors such as these may impact growth of the global  normal balloon catheter market . In addition, numerous other factors including rise in elder population, increasing investments in R&D activities associated with normal balloon catheters are further estimated to create growth opportunities for normal balloon catheter manufacturers. The global market for normal balloon catheter is set to exhibit an average CAGR throughout the forecast period (2017-2022). The global normal balloon catheter market will account for around US$ 2,000 Mn revenues by 2022-end. However, factors such as high costs related to angioplast...

Growing prevalence of peripheral vascular and coronary artery diseases has fuelled demand for scoring balloon catheter devices in the healthcare sector. Moreover, increasing demand for medical devices equipped with enhanced technology is projected to impact the global market growth of scoring balloon catheter positively. According to a recently published report, the global  scoring balloon catheter market  will reflect sluggish CAGR growth over the forecast period, 2017 – 2022. Factors Propelling Global Market Growth Increasing prevalence of coronary artery diseases has led to an upsurge in demand for scoring balloon catheter devices in the healthcare sector. Healthcare manufacturers prefer scoring balloon catheter devices over the conventional devices for the treatment of the coronary artery diseases attributed to limitations such as uncontrolled dissections including bailout stenting and insufficient luminal expansion. Moreover, healthcare professionals prefe...

The global  chromatography syringes market  is projected to exhibit an impressive expansion during the forecast period 2017 to 2022, according to a new study by Fact.MR. On the back of rising consumer concerns pertaining to food safety, coupled with continuous alterations in regulatory framework, demand for chromatography syringes is expected to witness a surge. Revenues from the global market for chromatography syringes will reach roughly US$ 85 Mn by 2022-end. Increasing Requirements in Research Activities to Fuel Market Growth of Chromatography Syringes Chromatography tests have become indispensable for approval of drugs. A number of technological advancements have been observed in chromatography syringes, which aim to cater demand from various industries such as semiconductor, chemical, food & beverage, biopharmaceutical, and biotechnology. Over the past few years, the requirements for research activities have been soaring, which include robust adoption o...

Global sales of cutting balloon catheter is projected to remain weak over the next five years. This is majorly attributed to the introduction of superior alternatives for carrying out minimally invasive cardiovascular and endovascular procedures. An array of cutting-edge catheters are available in the market owing to continuous research and development activities in the medical technology space. Moreover, increasing occurrence of cardiovascular disorders is putting an impetus on further innovation in catheter devices. Therefore, medical device manufacturers are concentrating on making multipurpose balloon catheters that will not be limited to any particular application. These aforementioned factors are deterring the prospects of the global  cutting balloon catheter market . According to the recent study conducted by Fact.MR, the global market for cutting balloon is estimated to stand at around US$ 181.6 Mn, reflecting a sluggish growth during the forecast period (2...

Growing need for minimally invasive technological devices has led to a surge in demand for neurointerventional devices in the healthcare sector. Moreover, increasing prevalence of vascular diseases is expected to impact growth of the global neurointerventional devices market positively. According to a compiled report, the global neurointerventional devices market will register a healthy CAGR growth over the projected period, 2017 – 2022. Factors Propelling Growth of the Global Market Increasing prevalence of atherosclerosis and ischemic strokes is expected to rev up demand for neurointerventional devices in the healthcare sector. Surge in preference of minimally invasive procedure among healthcare professionals has further fuelled demand for neurointerventional devices. Such factors are expected to fuel the global market growth of  neurointerventional devices market throughout 2022. Moreover, increasing prevalence of vascular disorders in spine, neck and head is p...

According to the latest report by Fact.MR, the automotive additives market is likely to experience above-average growth. The automotive additives market is estimated to reach US$ 8,251.8 million revenue by 2022 end. Manufacturers of automotive additives are focusing on developing highest performing solutions and with plastic emerging as the highest applied material in the interior, exterior and under the hood of the vehicle, automotive plastic additives are witnessing increased use in the automotive industry. Increasing number of automotive manufacturers are using plastics in the car. This trend of using plastic is also increasing as it helps in reducing the weight of the car. Hence, automotive addictive manufacturers are producing anti-scratch additives that can be used for interior and exterior applications. Manufacturers are also significantly investing in order to increase the speed and reduce production time involved in additive manufacturing. Meanwhile, additive manufact...

Measuring blood alcohol content (BAC) continues to remain a critical operation for medical professionals as well as law enforcement authorities. BAC levels of a patient have a defining impact on the conditions for performing any medical procedures. By using breathalyzers or breath analyzers, end-users can avoid the adoption of invasive blood sample tests to estimate BAC levels in the subjects. The Fact.MR report provides a comprehensive on how the global  breath analyzers market  will soar at impressive pace, procuring more than US$ 800 Mn value by the end of 2022. Forecast Highlights In 2017, more than two-third of the global breath analyzer market value was accounted by sales of active breathalyzers. Towards the end of forecast period, the global market for breath analyzers will witness a steadfast rise in demand for active breath analyzers, making them the top-selling product range. Revenues amassed from global sales of passive breath analyzers will also gai...

The global  electrosurgery devices market  is projected to exhibit an above-average expansion during the forecast period 2017 to 2022, according to a new study by Fact.MR. Revenues from the market is estimated to reach roughly US$ 8,000 Mn by 2022-end. Numerous surgical procedures have witnessed transformation from traditional ways to adoption of various minimally-invasive techniques, with changing phase of medical sector. The number of elder population around the world has been witnessing a surge, along with rising healthcare coverage. According to statistics offered by the WHO, global elder population is expected to account for approximately 2 Bn by 2050-end. The elder population is becoming highly prone to several diseases such as cardiac arrests, gastrointestinal diseases, and cancer, which in turn has driven the demand for minimally invasive techniques in order to treat patients who prefer to avoid hospital stay as well as healing time. High unmet needs for mi...

According to a recently released Fact.MR study, revenues from  dyslipidemia therapeutics market  surpassed US$ 36 billion in 2018. Low-density lipoproteins held approximately two-thirds of revenues from dyslipidemia therapeutics worldwide in 2018. As high LDL levels have been associated with increased risks of heart attacks, strokes, and other cardiovascular problems in humans, governments around the world are launching various campaigns to raise awareness about the adverse impact of high LDL levels in the blood. The growing prevalence of cardiovascular disorders worldwide has prompted individuals to effectively manage their LDL levels. To capitalize on the current trends prevalent in the dyslipidemia therapeutics market, pharmaceutical companies continue to strive towards developing new and improved therapies to lower LDL levels, and effectively manage the percentage of other lipids in the blood. A range of new treatments such as combination therapies, gene...